- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Gefitinib, as an EGFR-TKI inhibitor, is contraindicated in patients with specific genotypes, pregnancy, and organ dysfunction, while also payin...
Neratinib is an oral tyrosine kinase inhibitor, which is mainly used for adjuvant treatment and advanced treatment of HER2 positive breast canc...
As an anti-tumor drug, the side effects of Neratinib involve digestive system, skin reactions, and systemic symptoms, which require targeted ...
The contraindications for Tazemetostat mainly involve specific populations and drug interactions, and medication for special populations needs ...
The contraindications of Tazemetostat involve specific populations, dietary interactions, and treatment restrictions, and must be strictly foll...
Tazemetostat is an EZH2 methyltransferase inhibitor primarily used to treat tumors with specific gene mutations. Its indications include epithe...
Tazemetostat, as an EZH2 methyltransferase inhibitor, commonly has side effects involving hematological toxicity, gastrointestinal reactions, a...
Pazopanib is a multi-target tyrosine kinase inhibitor primarily used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma...
Pazopanib, as a multi-target tyrosine kinase inhibitor, commonly has side effects including liver toxicity, hypertension, and hematological abn...
Tofacitinib, as a JAK inhibitor, requires special attention to the risk of infection, cardiovascular events, and serious adverse reactions such...
